Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.

By Dr Wendy Winnall - PCFA Research TeamA recent prostate cancer study from Canada has received a lot of publicity. This study measured the risk of ...

Prostate cancer is highly treatable when detected early, as it carries a favourable prognosis. Therefore, awareness among ...

Kallisio, a company developing patient-specific precision-therapy solutions, announced that it has collaborated with Stanford Health Care to support the clinical implementation of its FDA-cleared ...

Treatments for localised prostate cancer have long been aimed at treating the whole prostate, either by surgical removal or by radiotherapy. However ...

From cancer care to portable food safety testing and climate-resilient crops, the IAEA demonstrated how nuclear technology is transforming lives well beyond the energy sector at last month’s Beyond ...

Telix Pharmaceuticals Limited (NASDAQ:TLX) is among the best NASDAQ stocks under $10 to buy. On December 15, RBC Capital assumed coverage on Telix Pharmaceuticals Limited (NASDAQ:TLX) with a Sector ...

There are no established treatment options for patients with meningioma recurring after surgery and radiotherapy.

Daiichi Sankyo begins patient dosing in DESTINY-Endometrial02 phase 3 trial of Enhertu in patients with HER2 expressing endometrial cancer: Tokyo Tuesday, December 23, 2025, 10:00 ...

Curasight A/S ("Curasight" or "the Company" – TICKER: CURAS) today announced the successful and safe dosing of the first patient in the Phase 1 trial using uTREAT in brain cancer (high grade gliomas).

Stryper frontman Michael Sweet, 62, says he was diagnosed with papillary thyroid cancer after noticing persistent changes in his singing voice and undergoing a biopsy that revealed a malignant thyroid ...